Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)

Clinical trial NCT00365209 · COMPLETED

Trial details

NCT number: NCT00365209
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy, no Evidence of Disease Tobacco Use Disorder

Start date: 2006-10-01
Primary completion: 2008-09-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.